• Busca persones
• Intranet

Recerca en Infertilitat de Barcelona Miguel Angel Checa

Publicacions 2024 (5)

• Gayete S^*, Moreno-Sepulveda J, Sánchez-Álvarez J, Prat M, Robles A, Espinos JJ, Checa MA. Anti-Müllerian hormone does not predict cumulative pregnancy rate in non-infertile women following four IUI cycles with donor sperm. J Assist Reprod Gen 2024: (en Premsa).
• González-Aranceta N, Alomar A, Rubio R, Maya S, Payà Panadés A, Piella G, Sukno F^*. Accuracy and repeatability of fetal facial measurements in 3D ultrasound: A longitudinal study. Early Hum Dev 2024; 193: 106021.
• Llurba E, Crispi F, Crovetto F, Youssef L, Delgado JL, Puig I, Mora J, Krofta L, Mackova K, Martinez A, Tubau A, Ruiz A, Paya A, Prat M, Chantraine F, Comas C, Kajdy A, Lopez-Tinajero MF, Figueras F^*, Gratacos E, PE37 study group. Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study. BMJ Open 2024; 14(3): e076201.
• Mañé L, Navarro H, Pedro-Botet J, Chillarón JJ, Ballesta S, Payà Panadés A, Amador V, Flores JA, Benaiges D^*. Early HbA1c Levels as a Predictor of Adverse Obstetric Outcomes: A Systematic Review and Meta-Analysis. J Clin Med 2024; 13(6): 1732.
• Rial-Crestelo M, Lubusky M, Parra-Cordero M, Krofta L, Kajdy A, Zohav E, Ferriols Pérez E, Cruz-Martinez R, Kacerovsky M, Scazzocchio E, Roubalova L, Socias P, Haslik L, Modzelewski J, Ashwal E, Castellá-Cesari J, Cruz-Lemini M, Gratacos E, Figueras F^*, RATIO37 Study Group. Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial. Lancet 2024; 403(10426): 545-553.